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Abstract
Background: Ericaulon buergerianum (Gujingcao) is an ophthalmic, anti-inflammatory and antimicrobial Chinese
medicinal herb. This study aims to investigate the neuroprotective effects of Ericaulon buergerianum ethanol extract
(EBE) and to elucidate its underlying action mechanism.
Methods: The viability of dopaminergic (DA) neuron in zebrafish was examined by anti-tyrosine hydroxylase (TH)
immunostaining. The locomotor activity of zebrafish was assessed with a digital video tracking system. The viability
and cellular damage of the PC12 cells were determined by MTT and LDH assays respectively. The nuclear
morphological changes in apoptotic cells were evaluated with DNA staining by Hoechst 33342 dye. Intracellular
nitric oxide (NO) was quantified by DAF-FM diacetate staining. The expression of inducible nitric oxide synthase
(iNOS) was determined by Western blot.
Results: EBE inhibited the 6-OHDA-induced decrease in total distance of movement in zebrafish. Pretreatments of
EBE (25, 50, 100 and 200 μg/ml) increased the viability of 6-OHDA-damaged PC12 cells in a dose dependent
manner. Protection against 6-OHDA-induced nuclear fragmentation and accumulation of apoptotic bodies was also
observed in EBE pretreated cells. Anti-oxidative (inhibition of NO production and iNOS expression in PC12 cells in
vitro) activities of EBE are related to its neuroprotective effects in 6-OHDA-induced DA neuron damage.
Conclusion: EBE exhibited significant neuroprotective activities in zebrafish, including recovery of dopaminergic
neuron loss caused by 6-OHDA in a dose-dependent manner in vivo, inhibition of 6-OHDA-induced decrease of
total distance in movement in zebrafish. The iNOS-NO pathway may be involved.
Background
A hydroxylated analogue of dopamine, namely 6-Hydro-
xydopamine (6-OHDA) which induces damage of dopa-
minergic neurons in vivo and in vitro, is commonly used
in model systems to mimic Parkinson’s disease of which
the main neuropathological feature is the loss of sub-
stantia nigra pars compacta (SNpc) dopaminergic (DA)
neurons. The toxic effects of 6-OHDA are mainly attrib-
uted to the formation of free radicals, inflammatory pro-
cesses and apoptosis [1,2].
Early studies indicated that NO participated in cellular
signaling pathways regulating broad aspects of brain
functions, such as synaptic plasticity, normal develop-
ment and neuronal cell death [3]. NO is synthesized
from L-arginine by nitric oxide synthase (NOS). Among
the three major isoforms of NOS, inducible NOS
(iNOS), a calcium-independent isoform, is regulated by
oxidative stress and some inflammatory cytokines [4].
The implication of NO in PD pathogenesis is supported
by the observations of unregulated iNOS expression in
activated microglia [5,6]. NO induces neuronal cell
damage by disrupting neuronal mitochondrial electron
transport chain function [7,8]. As a result, the agents
recovering the impaired mitochondrial function, sup-
pressing neuroinflammation and the production of NO
and iNOS may be beneficial for PD patients.
Ericaulon buergerianum (Gujingcao), an aquatic plant
native to Mainland China (eg Zhejiang, Guangdong and
Fujian provinces), Taiwan and Japan, is used in Chinese
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medicine as an anti-inflammatory and antimicrobial
agent [9]. According to Chinese medicine theories, it
expels Feng (Wind), clears Re (Heat) and brightens the
eyes. In Chinese Pharmacopoeia (2005), the capitulum
of Ericaulon buergerianum is one of the most frequently
used Chinese medicinal herbs, with flavonoids, volatile
oils, anthraquinone, naphthopyranones, protocatechuic
acid and c-tocopheryl acetate being the bioactive consti-
tuents [10]. Flavonoids such as patuletin hispidulin,
quercetin, quercetagetin and quercetagetin derivatives
and volatile oil such as palmitic acid, (Z, Z)-9, 12-octa-
cosane-dienoic acid are the two major classes of chemi-
cals in Ericaulon buergerianum [9,11]. Water extract of
Ericaulon buergerianum exhibits antimicrobial proper-
ties [11]. Ericaulon buergerianum demonstrates signifi-
cant therapeutic effects on headache, toothache,
nasosinusitis, night blindness, glaucoma, retinochoroidi-
tis, conjunctivitis and other eye diseases [12]. Guqing
Tang, a Chinese herbal formula consisting of Ericaulon
buergerianum and Celosia argentea (Qingxiangzi), is
used to treat headache and eye diseases [13].
The value of zebrafish (Danio rerio) for drug screen-
ing, target validation and toxicological studies is increas-
ingly recognized in recent years [14,15]. A region in the
zebrafish brain anatomically corresponding to the stria-
tum was identified in the forebrain [16]. Zebrafish also
display learning, sleeping, drug addiction and neurobe-
havioral phenotypes that are quantifiable and related to
those in humans [17,18]. Therefore, it is an ideal model
to study the neuroprotective effect of herbal medicine in
vivo.
The present study aims to investigate the neuroprotec-
tive effects of Ericaulon buergerianum in PC12 cells and




Heat-inactivated horse serum, fetal bovine serum (FBS),
penicillin and streptomycin were purchased from Gibco
Invitrogen (USA). Nutrient Mixture F12 Ham Kaighn’s
Modification (F-12 K) growth medium, dimethyl sulfox-
ide (DMSO) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) were purchased from
Sigma (USA). Cytotoxicity Detection Kit was purchased
from Roche Applied Science (Germany). The fluorescent
probe 4-amino-5-methylamino- 2’,7’-difluorofluorescein
diacetate (DAF-FM diacetate) and Hoechst 33342 dye
were purchased from Molecular Probes(USA). RIPA
lysis buffer, PMSF, protease inhibitor cocktail and BCA
protein assay kit were purchased from Pierce Biotech-
nology (USA). Polyvinylidene difluoride (PVDF) mem-
brane was purchased from Bio-Rad (USA). Anti-iNOS
was obtained from Cell Signaling Technology (USA).
ECL advanced western blotting detection kit was pur-
chased from Amersham (UK). All other reagents used in
this study were obtained from Sigma.
Extraction procedure
Crude herb of Ericaulon buergerianum was purchased
from ZhiXin Chinese Pharmaceutical Company in Hong
Kong and authenticated in the School of Chinese Medi-
cine, The Chinese University of Hong Kong according
to appearance identification of raw material and com-
parison of chemical constituents which have described
in Zhong-Yao-Zhi [19]. The crude herb was first ground
into powder with an electric grinder (Yongkang Weifeng
Electric Co. Ltd., China). The powder (100 g) was then
extracted with 80% ethanol for two hours, and the
extract was filtered and dried. Ericaulon buergerianum
ethanol (EBE) extract (10.8 g) was stored at -20°C.
Chemical analysis of Ericaulon buergerianum ethanol
extract
EBE was dissolved in DMSO (100 mg/ml) and filtered
with a 0.45 μm membrane filter. Then the filtrate was
analyzed on an Agilent 1100 series chromatographic sys-
tem (Agilent, USA) consisting of a vacuum degasser, a
binary pump, an auto-sampler, a column oven and a
diode array detector (DAD). Chromatographic separation
was achieved on a GL Sciences Inertsil ODS-4 column, 5
μm, 250 mm × 4.6 mm i.d. (GL Sciences, USA) at ambi-
ent temperature. The flow rate was 0.8 mL/min. The
mobile phase consisted of Milli-Q water (A) and aceton-
trile (B). The gradient elution was as follows: 10-35% (B)
in 0-40 min, 35-50% (B) in 40-50 min and 50-100% (B) in
50-60 min. Detection wavelength was set at 280 nm.
Injection volume was 10 μL. Evaluation of UV data was
performed on an Agilent ChemStation A.09.03 (Agilent,
USA) and DataAnalysis 2.2 (Bruker Daltonics, USA).
Fish maintenance
Embryos of wild-type (AB strain) zebrafish were col-
lected after natural spawning, staged according to stan-
dard criteria [20], and synchronously raised at 28.5°C.
Embryos were maintained in embryo medium (13.7 mM
NaCl, 540 μM KCl, pH7.4, 25 μM Na2HPO4, 44 μM
KH2PO4, 300 μM CaCl2, 100 μM MgSO4, 420 μM
NaHCO3, pH7.4). Since embryos received nourishment
from the attached yolk sac, no additional maintenance
was required.
Cell culture
Stock cultures of rat pheochromocytoma cells (PC12)
(CRL-1721) were purchased from American Type Cul-
ture Collection (ATCC, USA). They were cultured in F-
12 K supplemented medium with 15% (v/v) heat-inacti-
vated horse serum, 2.5% (v/v) FBS, penicillin (100 U/ml)
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and streptomycin (100 μg/ml) in a humidified atmo-
sphere of 5% CO2 at 37°C. The medium was changed
every other day.
Experimental design
Fertilized eggs obtained from mating pairs of adult zeb-
rafish were cultured in embryo medium. All experiments
were performed in 12-well plates with 20 embryos in
each well. Phenylthiourea (PTU, Sigma-Aldrich, USA)
was added for a final concentration of 0.003% to prevent
pigmentation of embryos, up to 2 day post fertilization
(dpf) and larvae (>2 dpf). 2 dpf zebrafish was exposed to
250 μM 6-OHDA and different concentrations (25, 50,
100 μg/ml) of EBE for 24 hours. Zebrafish co-treated
with 6-OHDA and Nomifensin (DAT inhibitor)/L-
nitroarginine methylester (L-NAME) were used as posi-
tive controls. Anti-TH immunostaining was performed
to evaluate the viability of dopaminergic neuron in the
brain of zebrafish.
PC12 cells were plated at a density of 104 cells/100 μl/
well in 96-well plates. EBE of different concentrations
(25, 50, 100 and 200 μg/ml) was added as pretreatment
to PC12 cells incubated in F-12 K medium supplemen-
ted with 0.5% (v/v) heat-inactivated horse serum for 12
hours at 37°C. Cells pretreated with L-NAME (250 μM)
for 12 hours served as positive controls. The mediums
were then discarded, and the cells were incubated for
another 12 hours with 6-OHDA (1 mM) dissolved in
0.5% (v/v) heat-inactivated horse serum at 37°C. A con-
trol group of untreated normal cells was also included.
The viability and cellular damage of the PC12 cells were
detected by the MTT and LDH assays respectively.
Anti-tyrosine hydroxylase (TH) whole mount
immunostaining
Zebrafish were fixed in 4% paraformaldehyde in phos-
phate buffered saline (PBS) for five hours, rinsed and
stored at -20°C in 100% EtOH. Fixed samples were
blocked (2% lamb serum in phosphate buffered saline
containing 0.1% Tween-20 (PBS-T), 0.1% BSA) for one
hour at room temperature. A mouse monoclonal anti-
tyrosine hydroxylase antibody (1:200 diluted in blocking
buffer, MAB318, Millipore, USA) was used as the pri-
mary antibody and incubated with the sample overnight
at 4°C. Samples were then washed with PBS-T six times
(30 min for each wash), followed by incubation with
secondary antibody according to the instruction of Vec-
tastain ABC kit (Vector Laboratories, USA). After being
stained, zebrafish were flat mounted with 3.5% methyl-
cellulose and photographed.
Testing of the locomotor activity
Fish behavior was analyzed with a digital video tracking
system (Viewpoint, ZebraLab, France). The system
consists of a digital video camera connected to a computer
system running the analysis software ZebraLab Man Rev
3.6B (ZebraLab, France). The locomotor activity of zebra-
fish larvae was assessed in a 96 well plate filled with 200 μl
embryo medium. At 7 dpf, the larvae were allowed to
habituate to the new environment for one hour and their
behavior was recorded for two minutes with the Viewpoint
ZebraLab system. Total distance of movement of each fish
per group was calculated.
MTT assay
3-(4, 5-dimethyl-2- thiazolyl) 2, 5-diphenyl-2H-tetrazo-
lium bromide (MTT) is a tetrazolium salt that can be
reduced to purple-colored formazan by live cells. For-
mazan is dissolved and the resulting solution can be
spectrophotometrically measured. Cells were incubated
for four hours at 37°C with MTT solution (0.5 mg/ml)
prepared in fresh 0.5% (v/v) heat-inactivated horse
serum. The medium was then discarded, and 100 μl of
DMSO was applied to each well to dissolve the violet
formazan crystals in intact cells. The absorbance was
measured at the wavelength of 490 nm by a multi-label
counter (Wallac VICTOR3™V, Perkin Elmer, Nether-
lands). Cell viability was expressed as a percentage of
the control (untreated cells). All assays were performed
in eight replicates and repeated at least three times.
LDH assay
Cell viability was determined by the activity of lactate
dehydrogenase (LDH) released into the incubation med-
ium when cellular membranes are damaged. Cells were
seeded in 96-well plates. After treatments, the released
LDH was measured according to the specifications of
Cytotoxicity Detection Kit (Roche, Germany). Briefly,
100 μl of culture medium was collected from each well.
The absorbance of the medium was measured at 490
nm with 690 nm as a reference wavelength in an auto-
matic microplate reader (Wallac VICTOR3TMV, perki-
nelmer, USA). Results are shown as percentage versus
6-OHDA group.
Hoechst 33342 staining
The nuclear morphological changes in apoptotic cells
were evaluated by DNA staining with Hoechst 33342
dye. Under fluorescent microscope, Hoechst 33342
stains the condensed chromatin in apoptotic cells much
more brightly than in normal cells. Cells were plated
into a 12-well plate at 105/well. Cells were pretreated
with EBE (50, 100, 200 μg/ml) for 12 hours, then treated
with 6-OHDA (1 mM) for 8 hours. Cells were then
stained with Hoechst 33342 (10 μg/ml) with RNase (5
μg/ml) in PBS for 15 min at room temperature, followed
by a 15-min fixation in 1% (w/v) paraformaldehyde.
Images were recorded with a fluorescent microscope
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(Carl Zeiss, Axiovert 200, USA) with a mounted camera
(Carl Zeiss, AxioCam HRc, USA).
Intracellular NO staining
Intracellular NO was evaluated by the fluorescent probe
4-amino-5-methylamino- 2’,7’-difluorofluorescein diace-
tate (DAF-FM diacetate). DAF-FM diacetate is cell-per-
meant and passively diffuses across cellular membranes.
Once inside cells, it is deacetylated by intracellular
esterases to become DAF-FM. The cells were seeded in
96-well black-bottom clear plates. After pretreated with
EBE and 6-OHDA for 12 hours and one hour respec-
tively, the cells were washed in PBS and incubated in
medium with PBS plus 2.5 μM DAF-FM diacetate for
30 min at 37°C in darkness. Then the cells were washed
twice with PBS and the fluorescence was evaluated in a
microplate reader (Wallac VICTOR3TMV, perkinelmer,
USA) at 495 nm (excitation) and 515 nm (emission).
Meanwhile, images were recorded by a fluorescent
microscope (Carl Zeiss, Axiovert 200, USA) with a
mounted camera (Carl Zeiss, AxioCam HRc, USA).
Western blot analysis
After treatment, PC12 cells were washed three times
with cold PBS and then incubated on ice with RIPA
lysis buffer with 1% PMSF and 1% protease inhibitor
cocktail for 30 min. Cell lysates were centrifuged at
12,500 × g (Hitachi, Japan) for 20 min at 4°C. The
supernatant was separated and the protein amount was
determined by the BCA protein assay kit. Sample buffer
(10% SDS, 250 mM Tris-HCL 6.8, 50% glycerol, 8%
DTT, 0.002% blue-bromophenol) was added and mixed
with protein at a ratio of 1:4, and boiled at 95°C for five
minutes. Protein samples (40 μg) were separated by 10%
SDS-poly-acrylamide gel electrophoresis and then trans-
ferred to a polyvinylidene difluoride (PVDF) membrane
(Bio-Rad, USA) for 90 min at 20 V. Subsequently, the
membrane was blocked with 5% non-fat milk in PBS
containing 0.1% Tween20 (PBST) for one hour at room
temperature. The blots were incubated overnight at 4°C
with various primary antibodies (Cell Signaling, USA)
including anti-iNOS (1:1000). After three washes with
PBS-T, the membranes were incubated with horseradish
peroxidase-conjugated secondary antibodies (1:2000) in
PBS-T with 5% non-fat milk for one hour at room tem-
perature. After repeated washes, proteins were visualized
with an ECL advanced Western blotting detection kit
(Amersham, UK) according to the manufacturer’s proto-
col. Protein bands were photographed by a Molecular
Imager ChemiDoc XRS (Bio-Rad, USA).
Statistical analysis
Data are represented as mean ± standard deviation (SD).
One-way ANOVA was used to detect significant
differences among concentration groups in the experi-
ments. Newman-Keuls Multiple Comparison Test was
used to test the statistical significance of the difference
between the concentration group and the control (vehi-
cle) group. GraphPad Prism statistical software (Graph-
Pad Software, USA) was used for all calculations. P <
0.05 was considered as statistically significant.
Results and Discussion
Quality control of EBE
High-performance liquid chromatography (HPLC)
coupled with (DAD) was used to generate the chemical
profile of EBE (Figure 1). The HPLC fingerprinting may
be used as a reference for the purpose of quality assur-
ance for any future experiments related to EBE.
Protection of 6-OHDA-induced dopaminergic neuron loss
in zebrafish
All the tyrosine hydroxylase (TH)-positive neurons in
zebrafish diencephalons are dopaminergic neurons [21].
Anti-TH immunostaining was used to compare the via-
bility of dopaminergic neurons in zebrafish receiving dif-
ferent drug treatments (Figure 2). 2 dpf zebrafish were
exposed to 250 μM 6-OHDA for 24 hours, dopaminer-
gic neurons in the ventral diencephalic clusters (indi-
cated by white bracket) were significantly reduced when
compared to the control. Co-treatment with 6-OHDA
and EBE for 24 hours recovered 6-OHDA-induced
dopaminergic neuron loss in a dose-dependent manner
(P = 0.046 at 25 μg/ml, *** P < 0.0001 at 25 and 50 μg/
ml compared with 6-OHDA treatment alone) (Figure 3).
Nomifensin (DAT inhibitor) and L-NAME were used as
positive controls, both significantly reversed the loss of
dopaminergic neurons caused by 6-OHDA (P < 0.0001).
Inhibition of 6-OHDA-induced decrease in total distance
of movement in zebrafish
The total distance of movement by 6-OHDA-lesioned
fish was significantly decreased when compared with the
control group. EBE inhibited 6-OHDA-induced reduc-
tion of total distance of movement in zebrafish in a
dose dependent manner (Figure 4).
Dose-dependent reduction of 6-OHDA-induced cell death
in PC12 cells
The cell viability of PC12 cells exposed to 1 mM 6-
OHDA for 12 hours was significantly decreased (46.2%
± 9.2%; P < 0.0001) compared with the control group
(Figure 5A). Pretreatment with EBE of various concen-
trations (25, 50, 100 and 200 μg/ml) for 12 hours pro-
tected PC 12 cells against 6-OHDA-induced cellular
damage in a dose-dependent manner. Compared with
the control, the survival rates of the EBE treatment
groups (25, 50, 100, 200 μg/ml) were 63.4% ± 7.3%,
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77.1% ± 4.5%, 88.8% and 102.3% respectively. Toxicity
was not observed when the cells were treated with 200
μg/mL alone. LDH is released from the cells following
membrane damage, as a sign of cell death. Evaluation of
LDH release revealed a significant increase after 6-
OHDA exposure in PC12 cells while pretreatment with
EBE suppressed the 6-OHDA-induced LDH release in a
dose dependent manner (Figure 5B). L-NAME is an
inhibitor of NOS and served as a positive control. Sig-
nificant protective effects were found in the positive
Figure 2 EBE recovered 6-OHDA-induced dopaminergic neuron loss in zebrafish. (A-H) 2 dpf zebrafish was exposed to 250 μM 6-OHDA
and different concentrations of EBE or 100 μM Nomifensin or 100 μM L-NAME or 100 μg/mL EBE for 24 hours, except the control. The viability
of dopaminergic neurons of the zebrafish (indicated by white brackets) was evaluated with anti-tyrosine hydroxylase (TH) immunostaining.
Ventral view: anterior to the top.



















Figure 1 HPLC/UV chromatogram of Ericaulon buergerianum ethanol extract. Column: ODS-4 column; The flow rate: 0.8 mL/min; The
mobile phase consisted of Milli-Q water (A) and acetontrile (B) with a gradient elution of 10-35% (B) in 0-40 min, 35-50% (B) in 40-50 min and
50-100% (B) in 50-60 min.
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control groups with both MTT and LDH assays (Figures
5A and 5B).
Suppression of 6-OHDA-induced apoptosis in PC12 cells
Apoptosis is morphologically characterized by cell
shrinkage, chromatin condensation and nuclear frag-
mentation. To identify whether EBE reverses 6-OHDA-
induced PC12 cell apoptosis, we used DNA staining
with Hoechst 33342 to evaluate nuclear condensation.
Normal untreated cells appeared circle or elliptical
where no condensation of the nucleus was observable
(Figure 6A). In contrast, bright condensed dots known
as apoptotic bodies (indicated by arrows in Figure 6B)
were clearly identified after exposure to 1 mM 6-OHDA
for eight hours. Apoptotic bodies are generated when
chromatin fragments are packaged in apoptotic cells,
and are commonly accepted as a marker of apoptosis.
Reductions in colony density and cell size were also
observable when treated with 6-OHDA. These changes
in nuclear characteristics of apoptosis were inhibited
when the cells were pretreated with EBE of different
concentrations (25, 50, 100, 200 μg/ml) (Figures 6C-F).
Inhibition of 6-OHDA-induced NO over-production and
down-regulated iNOS over-expression
Figure 7 shows that 6-OHDA exposure led to a roughly
1.5-fold increase in NO production compared with the
control group; similar elevation was also observed when
SNP (sodium nitroprusside dehydrate, NO generator)
was added. This increase in NO level was reduced in a
concentration-dependent manner by pretreatment with
EBE in a 25-200 μg/mL range for 12 hours (Figure 7E-
H). Pretreatment with 250 μM L-NAME for 12 hours
also significantly (P = 0.044) reduced this 6-OHDA-
induced NO over-production. Pretreatment with higher
concentrations (50, 100, 200 μg/ml) of EBE suppressed
the elevated NO production more efficiently than L-
NAME (Figure 7D). Furthermore, DAF-FM diacetate
staining was photographed with a fluorescent micro-
scope (Figure 7A-H). The expression of iNOS was up-
regulated by 6-OHDA exposure in Western blot analysis
and such up-regulation was prevented by pretreatment
with EBE (Figure 8A).
Further studies
Many flavonoids, such as those derived from Vitis vini-
fera (grape), Camellia sinensis (tea), Theobroma cacao
(cocoa) and Vaccinium spp. (blueberry), exert their neu-
roprotective actions via (1) modulating intracellular sig-
naling cascades controlling neuronal survival, death and
differentiation, (2) affecting gene expression and (3)
interacting with mitochondria [22]. The neuroprotective
effects of volatile oils have also been reported; for
Figure 3 Quantitative analysis of area of TH+ neuron in
zebrafish brain. All data expressed as percentage of control group,
each bar represents mean ± SD. +++ P < 0.0001 versus control
group (without 6-OHDA treatment); * P = 0.046 versus 6-OHDA-
treated group; *** P < 0.0001 versus 6-OHDA-treated group. All
experiments were repeated 3 times.
Figure 4 EBE inhibited 6-OHDA-induced decrease of total
distance of movement in zebrafish. Quantification of the
swimming parameter of zebrafish: 4 dpf wild type zebrafish larvae
were treated with 6-OHDA (250 μM) and EBE (25 and 50 μg/mL) for
three days. The locomotor activity of zebrafish was assessed at
seven dpf. All results were expressed as total distance of movement
traveled by the larvae, + P = 0.032 versus control group (without 6-
OHDA treatment); * P = 0.041, ** P = 0.007 versus 6-OHDA-treated
group. All experiments were repeated 3 times.
Wang et al. Chinese Medicine 2011, 6:16
http://www.cmjournal.org/content/6/1/16
Page 6 of 10
Figure 5 EBE dose-dependently reduced PC12 cell death induced by 6-OHDA. PC12 cells were pretreated with or without EBE for 12 hours,
pretreatment with 250 μM L-NAME for 12 hours served as positive control. The cells were exposed to 1 mM 6-OHDA for another 12 hours after
pretreatment. (A) Cell viability was measured by MTT assay and results were expressed as percentage of control group (without 6-OHDA
treatment). (B) Cell viability was measured as the percentage of released LDH. +++ P < 0.0001 versus control group (without 6-OHDA treatment);
* P = 0.028 versus 6-OHDA group; *** P < 0.0001 versus 6-OHDA group. Each experiment was repeated 3 times.
Figure 6 EBE reduced apoptosis induced by 6-OHDA in PC12 cells. Cells were stained with DNA-binding fluorescent dye Hoechst 33342. (A)
Control: untreated group; (B) 6-OHDA-treated group (1 mM, 8 hours): chromatin condensation and DNA fragmentation were indicated by the
white arrows; (C-F) EBE-pretreated groups (25, 50, 100 and 200 μg/mL respectively, 12 hours), followed by 6-OHDA exposure (1 mM, 8 hours):
less apoptotic bodies were identified, colony reduction and cell shrinkage induced by 6-OHDA were also reversed.
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Figure 7 EBE inhibited 6-OHDA-induced nitric oxide (NO) over-production in PC12 cells. PC12 cells were pretreated with or without 250
μM L-NAME, 100 μM SNP and 25, 50, 100 and 200 μg/mL EBE for 12 hours, then exposed to1 mM 6-OHDA for another hour. (A-H) Intracellular
NO was identified using fluorescent indicator, DAF-FM diacetate; (I) The NO fluorescent intensity was quantified by a multi-label counter. ++ P =
0.008 versus control group (without 6-OHDA treatment); * P = 0.044 versus OHDA group; ** P = 0.005 versus OHDA group. All experiments were
repeated 3 times.
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example, curcuma oil modulates the NO system
response to cerebral ischemia/reperfusion injury in rats
[23]. As EBE is the ethanol extract of Ericaulon buerger-
ianum which is rich in flavonoids and volatile oils, flavo-
noids and volatile oils may be the active ingredients in
EBE. Further studies are warranted to confirm this.
Conclusion
EBE exhibited significant neuroprotective activities in
zebrafish, including recovery of dopaminergic neuron
loss caused by 6-OHDA in a dose-dependent manner in
vivo, inhibition of 6-OHDA-induced decrease of total
distance in movement in zebrafish. The iNOS-NO path-
way may be involved.
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